Literature DB >> 3404237

Tethered cord syndrome of delayed onset following repair of myelomeningocele.

N Tamaki1, K Shirataki, N Kojima, Y Shouse, S Matsumoto.   

Abstract

Nine (15%) of 60 patients with repaired myelomeningocele exhibited late deterioration of neurological function with a tethered cord syndrome. Dense adhesions at the lowest laminae and at the site of previous repair were the most common findings at surgery. Postoperatively, 71% of the patients improved. Magnetic resonance (MR) imaging was performed in 29 of the 60 patients. Eight of these 29 patients exhibited a tethered cord syndrome. The MR images in all patients showed a low-lying conus fixed at the site of previous repair, irrespective of the presence or absence of a tethered cord syndrome. The MR images were classified into two groups depending upon the site of adhesions: Group A had potential sites of tethering at the ventral aspect of the last laminae and at the site of previous repair, and Group B showed the adhesion point only at the site of previous repair. Most patients with a tethered cord syndrome were found to be in Group A; conversely, most patients without the syndrome were in Group B. An enlarged low conus was seen in symptomatic patients more commonly than in those without this syndrome. It is concluded that the presence of adhesions specifically at the last laminae as well as a widened low-lying conus may be the cause of tethered cord syndrome in patients with repaired myelomeningoceles. A clear understanding of the tethering process and preoperative evaluation of potential sites of tethering, based on the MR findings, are very important for planning surgery. The release of adhesions at the lowest laminae by laminectomy appeared essential for improvement.

Entities:  

Mesh:

Year:  1988        PMID: 3404237     DOI: 10.3171/jns.1988.69.3.0393

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  16 in total

1.  Lesson of the week: tethered cord syndrome after myelomeningocoele repair.

Authors:  N O Jeelani; T Jaspan; J A Punt
Journal:  BMJ       Date:  1999-02-20

2.  Ambulation in adults with myelomeningocele. Is it possible to predict the level of ambulation in early life?

Authors:  Aase Seitzberg; Marianne Lind; Fin Biering-Sørensen
Journal:  Childs Nerv Syst       Date:  2007-08-21       Impact factor: 1.475

3.  Tethered-cord syndrome after repair of meningomyelocele.

Authors:  C Balasubramaniam; J P Laurent; C McCluggage; D Oshman; W R Cheek
Journal:  Childs Nerv Syst       Date:  1990-06       Impact factor: 1.475

4.  The initial treatment of meningocele and myelomeningocele lesions in adulthood: experiences with seven patients.

Authors:  Kamil Melih Akay; Engin Gönül; Emin Ocal; Erdener Timurkaynak
Journal:  Neurosurg Rev       Date:  2002-06-18       Impact factor: 3.042

5.  Review of tethered cord syndrome with a radiological and anatomical study: case report.

Authors:  L G Giles
Journal:  Surg Radiol Anat       Date:  1991       Impact factor: 1.246

6.  Surgical treatment of late neurological deterioration in children with myelodysplasia.

Authors:  M Caldarelli; C Di Rocco; C Colosimo; G Fariello; M Di Gennaro
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  Clinical features and MR imaging in children with repaired myelomeningocele.

Authors:  R Bono; M Inverno; G Botteon; M G Bruzzone; M A Vaghi; C L Solero; E Perlasca; E Fedrizzi
Journal:  Ital J Neurol Sci       Date:  1993-10

8.  Tethered cord after spina bifida aperta: a longitudinal study of somatosensory evoked potentials.

Authors:  R Boor; M Schwarz; B Reitter; D Voth
Journal:  Childs Nerv Syst       Date:  1993-09       Impact factor: 1.475

9.  Spinal dysraphism: a neurosurgical review for the urologist.

Authors:  José Murillo B Netto; André N Bastos; André A Figueiredo; Luis M Pérez
Journal:  Rev Urol       Date:  2009

10.  Occult dysraphism in adulthood: clinical course and management.

Authors:  J Klekamp; A J Raimondi; M Samii
Journal:  Childs Nerv Syst       Date:  1994-07       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.